PQ 306
306. Deputy Kate O'Connell asked the Minister for Health his views on whether a quality-adjusted life year, QALY, based health technology assessment is an appropriate mechanism for assessing the cost and clinical effectiveness of an orphan medicinal product; if the HSE has found orphan medicinal products to be cost effective under its current health technology assessment; and if he will make a statement on the matter. [52838/17]
Introduced
12 December 2017
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
12 December 2017
Summary
306. Deputy Kate O'Connell asked the Minister for Health his views on whether a quality-adjusted life year, QALY, based health technology assessment is an appropriate mechanism for assessing the cost and clinical effectiveness of an orphan medicinal product; if the HSE has found orphan medicinal products to be cost effective under its current health technology assessment; and if he will make a statement on the matter. [52838/17]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medical Products
Medical Products
xml · EN · 12 December 2017
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2017-12-12/306/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2017-12-12/pq_306